Rapid Rhino

Rapid Rhino is a specialized medical device brand focused on the development and commercialization of epistaxis (nosebleed) and sinonasal packing products. The brand is distinguished by its proprietary carboxymethylcellulose (CMC) technology, which creates a protective, moist interface that minimizes tissue trauma during device removal. Originally an independent entity known as Applied Therapeutics, it was acquired by ArthroCare in 2004 and subsequently became part of Smith & Nephew in 2014. Its product portfolio is a standard of care in emergency departments and ENT clinics for managing acute nasal hemorrhages and post-surgical recovery.